| Financial Year |
March 31 2023 |
| Monetary Funds |
829,179,634.72 |
| Held-for-trading Financial Assets |
670,621,346.31 |
| Notes Receivable |
205,949.06 |
| Accounts Receivable |
928,566,119.28 |
| Advances to Suppliers |
341,432,474.70 |
| Other Receivables |
44,470,777.84 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,011,938,060.44 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
91,404,140.51 |
| Total Current Assets |
5,512,330,253.58 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
2,707,488,210.02 |
| Under-construction Projects |
668,446,327.23 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
537,935,733.89 |
| R&D expenses |
19,645,860.10 |
| Goodwill |
196,264,229.88 |
| Long-Term Deferred and Prepaid Expenses |
11,444,424.63 |
| Deferred Income Tax Assets |
46,966,068.80 |
| Other Non-Current Assets |
110,403,033.96 |
| Sub-Total of Non-Current Assets |
4,313,140,480.14 |
| Total Assets |
9,825,470,733.72 |
| Short-Term Loans |
852,937,240.26 |
| Trading Financial liabilities |
-- |
| Notes Payable |
602,343,227.19 |
| Accounts Payable |
600,328,095.93 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
46,511,780.00 |
| Taxes Payable |
32,459,997.13 |
| Interest Payable |
-- |
| Dividend Payable |
4,007,305.65 |
| Other payables |
946,934,724.71 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
418,831,809.22 |
| Other Current Liabilities |
150,637,936.55 |
| Sub-Total of Current Liabilities |
3,698,319,285.86 |
| Long-term Loans |
1,508,109,835.01 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
15,858.59 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,618,782,000.66 |
| Total Liabilities |
5,317,101,286.52 |
| Paid-In Capital(Or Share Stock) |
944,606,894.00 |
| Capital Surplus |
2,588,106,350.23 |
| Surplus Reserve |
47,448,083.46 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
531,444,595.33 |
| Minority Stockholder's Interest |
396,426,789.73 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,111,942,657.47 |
| Owner's Equity（Stockholder's Equity） |
4,508,369,447.20 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
9,825,470,733.72 |
